noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

News > Science

related tags Geology Biology Biotechnology Research Space Program Scientific Institutions Scientific Institutes Space Agencies

Results Science

Merck & Co. Inc.

SOLO-1 Phase 3 Trial Demonstrates LYNPARZA® (olaparib) Maintenance Therapy Cut the Risk of Disease Progression or Death by 70 Percent in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer

-4h 34m
GE - General Electric Company

The 5 Coolest Things On Earth This Week

-5h 22m
G1 Therapeutics Inc.

G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer

-6h 16m
Leap Therapeutics Inc.

Leap Therapeutics Presents Esophagogastric Cancer Data at ESMO 2018 Annual Congress

-8h 20m
Incyte Corporation

Summary ToggleIncyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

-8h 20m
Loxo Oncology Inc.

Loxo Oncology Announces Larotrectinib Clinical Update in Patients with TRK Fusion Cancers at the European Society for Medical Oncology 2018 Congress

-9h 11m
Mirati Therapeutics Inc.

Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress

-9h 53m
The United States Navy

Histopathology on USNS Comfort

-16h 20m
Gilead Sciences Inc.

Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting

-20h 34m
John Wiley & Sons Inc.

Immune Therapy Generates Promising Results in Hard-to-Treat Ankylosing Spondylitis

-21h 31m